Skip to main content

Patients’ perspectives on, experience with and concerns about crohn's disease: insights from Chinese social media



The aim of this study was to explore the experience and perceptions of patients with Crohn’s disease in China.


Data mining was used to investigate posts in Crohn’s disease online medical communities. The data were collected through the crawler code, and latent Dirichlet allocation (LDA) and grounded theory were used to mine the theme features after data cleaning.


In analyzing the topic characteristics of online posts, LDA divided 6757 posts into 15 topics on four aspects: seeking disease information, making decisions on medication use, psychological burden, and communicating about diet and nutrition.


Overall, social media is patient-centric and helps us better understand the experiences and perceptions of patients. This study can help medical staff predict the thoughts and concerns of Crohn's disease patients during the treatment process, facilitate doctor-patient communication, and assist in the formulation of medical policies.

Peer Review reports

Core Tips

What is already known?

Patients with Crohn's disease face many difficulties and challenges, especially in the context of Chinese culture, such as poor quality of life, lack of health education and social support, etc. in addition, there are few patient-centered studies.

What is new here?

We collect extensive, high-quality and authentic patient experiences through social media to fully understand the perspectives, experiences and concerns of Chinese Crohn's disease patients.

How can this study help patient care?

This study could help medical staff predict the thoughts and concerns of Crohn's disease patients during treatment, facilitate doctor-patient communication, and help shape healthcare policy.


Crohn's disease is a subtype of inflammatory bowel disease (IBD) characterized by a chronic inflammatory disorder of the gastrointestinal tract that requires lifelong medical treatment [1]. In the past, IBD has been considered a disease of the Western world; however, data from the last decade show a rising incidence in newly industrialized countries in Asia [2]. The incidence and prevalence of IBD are increasing rapidly, and it is no longer rare in China [3]. Considering the large population of China, it is predicted that the total number of IBD patients in China may exceed that in North America in the near future [4]. This evidence indicates that China will soon have a huge number of IBD patients, which will inevitably bring enormous challenges to the health system.

In the past, qualitative studies, such as questionnaire surveys and semistructured interviews, were used for patients with Crohn’s disease [5, 6]. One qualitative study explored the experience of twenty-five participants with IBD and moderate-to-severe symptoms and suggested that psychotherapists working with IBD need advanced skills to gain a clear understanding of the different processes impacting patients’ mood and levels of anxiety [6]. Another qualitative study reported on the challenges of living with and managing IBD and found that physical symptoms were the greatest challenges, negatively affecting patients’ psychological and social well-being and reducing their quality of life [7]. These qualitative studies focused on quality of life and mental health-specific interviews [6, 8]. However, such studies were designed and guided by researchers rather than being the direct perspective of patients. Most studies did not distinguish between subtypes of IBD: ulcerative colitis and Crohn's disease.

With the development of the internet, patients have gradually come to rely on it. An increasing number of patients tend to search online for relevant information before seeing a doctor or obtain medical services through the internet [9]. A study in the US found that 59% of users search for health information on the internet [10]. In addition, social media plays an important role for many people, including adolescents [11], pregnant women [12], and college students [13], especially in the context of COVID-19 [14]. Gabriela Gonzalez et al. [10] assessed women's knowledge, patient experience, and treatment decision making regarding overactive bladder using social media posts. These results have been of great help in clinical and nursing practices.

Social media provides us with an angle to better understand patients, especially in China, which has 800 million internet users. To gain a better understanding of the knowledge, perceptions and experience of Crohn's disease patients in Chinese online networks, we collected Crohn's disease-related posts from Chinese social media and explored the experience, perceptions, needs and difficulties of patients.

Materials and methods

Study design

Baidu Tieba ( is the largest Chinese online community; it consists of a variety of subcommunities on different topics and gathers massive user groups with different interests. As of May 20, 2022, the Crohn's disease bar ( had more than 10,000 followers and more than 150,000 posts and replies. The massive amount of user data generated in this open community is of great significance for analyzing Crohn's disease patients’ experience and perceptions.

In this study, we collected 12 years of posts from the Crohn's disease bar through data mining. After data cleaning, the latent Dirichlet allocation (LDA) topic model and grounded theory were used to explore the theme and understand the experience and perceptions of Crohn's disease patients based on the perspective of social media. The workflow is presented in Fig. 1.

Fig. 1
figure 1

Flow chart of the study

Data collection and cleaning

All user posts (including posts, comments and replies) were written in Chinese and published online between December 6, 2009, and May 20, 2022.

By using the ‘request’ and ‘selenium’ packages and fast web crawling based on Python, we extracted the required data from web pages. A total of 41,822 pieces of raw data were collected. Subsequently, each post was combined with corresponding comments and replies into a single document for further analysis.

We removed blank lines, duplicate text, and special symbols, numbers and letters from the text, further eliminated text with a string length of less than 10, and retained only Chinese strings. Additionally, we manually reviewed advertised posts and posts unrelated to Crohn's disease. Finally, a total of 6757 posts were used for further analysis.

Qualitative methods: grounded theory

Once the posts were identified, we randomly selected 200 posts and used grounded theory methods for analysis, as described by Charmaz [15]. This number was chosen to achieve thematic saturation, meaning the point at which themes begin to be repeated.

Grounded theory is an iterative, hypothesis-generating approach that emphasizes the generalization or emergence of information from data to establish a theory or model [16, 17]. Two investigators individually coded line-by-line to identify prominent issues and concepts. Next, we reviewed the codes and incorporated them into coding categories, which are groups of similar concepts and themes. Data analysis was completed by NVivo12 plus software.

Quantitative methods: LDA topic model

In addition to qualitative analysis, we quantitatively analyzed all posts using the LDA probabilistic topic model [18]. LDA assumes that documents are generated based on a certain number of topics and that a given number of topics can be extracted from a corpus containing a certain number of documents [19]. It is an excellent probabilistic model that performs well in topic modeling and has been widely applied in research [20].

In this research, we applied LDA to extract a certain number of topics from the cleaned dataset. To determine the number of topics, the coherence scores were taken into consideration [18]. Topic coherence is the most effective method of measuring the quality of topics and one of the important techniques used to estimate the number of topics. It measures the sentence similarity of each topic in the dataset, and higher scores represent the most appropriate number of model topics [21]. After the optimal model is determined, another Python package, ‘pyLDAvis’, was adopted to visualize the topic extraction results. We could then view the topic distance and overlap in a two-dimensional space. The size of different circles represents the topic distribution.


LDA topic model analysis

We studied 6757 high-quality posts from Chinese social media that focused on Crohn's disease. Consistency scores were calculated from 1 to 60 topics to obtain the optimal number of topics (Fig. 2), and a total of 15 topics were found (Fig. 3).

Fig. 2
figure 2

Coherence scores for different numbers of topics. The number of topics with the highest score is 15

Fig. 3
figure 3

Intertopic distance map

Table 1 shows the representative term cluster with the each term’s prevalence and assigned topic. The majority of posts (22.8%) focused on discussions surrounding diagnosis and symptoms, and 13% talked about the impact of the disease on individuals and family. Some people (11.9%) expressed concern about complications and surgery, and 9% of the posts expressed expectations for new therapies. Among the patients, 6.9% wanted to explore the etiology and mechanism of the disease, 6.3% thought they lacked professional treatment support, and 5.1% were confused about diet and nutrition. Traditional Chinese medicine (TCM) (4.8%), biological agents (4.7%) and traditional therapeutic drugs (4.7%) were the most discussed drugs. Health insurance policies (3.3%), medication experience (2.7%) and possible drug side effects (2.1%) were also concerns for patients with Crohn's disease. In addition, financial situation (1.6%) and social impact (1%) were among their burdens.

Table 1 Representative term cluster with prevalence and assigned topic

Grounded theory

We identified nine preliminary topics related to the experience and perceptions of Crohn's disease patients during data analysis using grounded theory: (i) seeking disease information, (ii) improving quality of life, (iii) mental burden, (iv) medications and treatment modalities, (v) diet and nutrition, (vi) disease progression, (vii) economic burden, (viii) peer support, and (ix) IBD expert panel support.

Most of the topics encoded by grounded theory were established in LDA topic modeling; however, an additional important topic was found in our coding analysis: peer support. Peer support was usually in the posts that shared patient experience and treatment experience. Patients with Crohn's disease can be encouraged to adhere to treatment (e.g., “I would like to share my treatment experience and hope to help you”). In addition, peer support also appeared in depressed posts for which encouragement, support and suggestions usually appeared in replies (e.g., “Cheer yourself up, you will recover”).

Results of mixed methods

Topics were generated by LDA and compared to the themes identified in the grounded theory analysis. We identified five themes with several subthemes, which are summarized in Fig. 4.

Fig. 4
figure 4

Themes identified by mixed methods

Results during the COVID-19 pandemic

The LDA model did not generate a topic related to the COVID-19 pandemic. As a result, we manually retrieved relevant posts about the COVID-19 pandemic from December 1, 2019 to May 20, 2022. The search terms included 'COVID-19', 'infection', 'pneumonia', 'epidemic situation' and 'epidemic prevention' resulting in 54 high-quality posts.

Consonant with a grounded theory approach, data were coded and analytic induction was used to identify key themes. Four main themes were identified: (i) Preventive and protective measures (e.g., “Is the resistance to the COVID-19 worse for Crohn’s disease patients than it is for ordinary people?”), (ii) COVID-19 vaccination decision (e.g., “Are there any patients who have been vaccinated with biological agents and with the COVID-19 vaccine? Can we get vaccinated?”), (iii) Drug use after COVID-19 infection (e.g., “Can biological agents be used when infected with COVID-19?”), (iv) Concerns about the shortage of medical resources (e.g., “For the sake of epidemic safety, the hospital temporarily closed the biological reagent injection room.”).


Health and disease belong to the category of biomedicine but also involve social, political and economic dimensions [22]. Our research summarized posts in the Crohn’s disease bar over the previous 12 years and conducted a comprehensive analysis through two methods: grounded theory and the LAD topic model. In contrast to previous interview studies with small sample sizes, this study analyzed Chinese patients with Crohn's disease from the perspective of social media. An enormous and comprehensive dataset identified the prominent concerns of patients with Crohn's disease. This study provides novel insight into patients’ experiences with Crohn's disease and identifies actionable needs that may improve their quality of life.

The need for shared decision making in IBD has become a consensus among IBD physicians worldwide [23]. However, there is a large gap between doctors and patients in their knowledge and information about diseases. Apart from online consultation, Crohn's disease patients seem to have few ways to acquire such knowledge. Our study confirmed that 56.9% of Crohn's disease patients urgently want more information about the disease, including diagnosis, symptoms, pathology, complications, surgery, new therapies and professional treatment support. This need is more urgent for patients who have symptoms but have not been diagnosed or have difficulty in diagnosis. Consulting patients who have been diagnosed is the most common method. For instance, some people described their symptoms and indicated that they have undergone some physical examination (but had not received feedback). They were very afraid, especially after they searched for information about Crohn's disease on the internet. Some low-quality answers often have this effect. Patients' consultation of social media negatively influenced the diagnostic and therapeutic decisions. For example, some posts mentioned that the anesthetics used in painless enteroscopies would damage the memories. This misunderstanding has always existed in China and has negatively affected many people, causing them to suffer needlessly by refusing to undergo anesthesia during an enteroscopy. In addition, some posts mentioned consulting experts and hospitals with experience in treating Crohn's disease. Some patients find their disease progressing because of misdiagnosis, untimely treatment and nonstandard treatment.

Encouragingly, many Crohn's disease patients in China had shared their experiences through video platforms, such as the Chinese Tik Tok and Bilibili video platforms; some self-media medical accounts also disseminated Crohn's disease knowledge through popular science articles and videos. In recent years, the Chinese Crohn's and Colitis Foundation (CCCF) [24], a large nongovernmental public welfare organization that is committed to improving the quality of life of IBD patients in China by providing social resources, has made great contributions through patient education, public awareness, helping to train IBD specialists, etc. In addition, an increasing number of hospitals are actively training IBD specialists and establishing multidisciplinary teams (MDTs) [25].

Pharmacotherapy is the first step in treating IBD [26]. The main medicine for the management of Crohn's disease works by suppressing an overly active intestinal immune system [26]. Several monoclonal antibodies have been approved for the treatment of Crohn's disease, such as anti-TNF agents [27] and anti-integrin agents. In addition, the use of these biologics in combination with a conventional immunosuppressant may yield superior outcomes and improve the durability of therapy [28, 29]. In our analyses, we also found that more than 1/4 of the posts discussed the drug treatment of Crohn's disease, and seven subthemes were mentioned repeatedly. Biological agents, traditional therapeutic drugs, hormones and TCM were the drugs of most concern to patients. Other patients' medication experience (efficacy and recommendations) and side effects also affected their medication decisions. Medical insurance policies and their own financial situation restricted them from choosing better drugs.

Interestingly, Chinese patients with Crohn's disease were willing to use TCM for treatment, especially when biological agents failed. Cai et al. used semistructured interviews with 14 IBD patients using TCM and explored their reasons and experience of decision-making [30]. The results showed that patients initiated TCM treatment due to the unsatisfactory effects of other therapies. TCM has been widely used to treat IBD in China; however, systematically determining its efficacy in IBD treatment is still challenging [31].

The benefits and risks of treatment are the primary consideration of doctors, which also places huge decision-making pressure on patients. A previous network survey on Crohn's disease patients found that the acceptable risk of drug treatment for Crohn's disease patients depends on the severity of the disease and the expected benefits. Especially for patients with mild to moderate cases, the acceptance of risk is low [23]. Another study showed that when Crohn's disease patients decide to use biological agents, they will comprehensively consider the safety and efficacy of those agents. Among them, safety accounted for 54% of the attention and the efficacy only 28% [32]. Our results are consistent with these findings. Many patients posted questions about the side effects of drugs and expressed their concerns. The experience of other patients often affected their decisions about medicine.

In our study, financial burden was another important influencing factor of drug use decisions, which was closely related to medical insurance policies. A retrospective study of the medical expenses of Crohn's disease patients based on a medical insurance database in the United States showed that the average lifetime medical cost of Crohn's disease patients was $416,352 higher than that of non-IBD patients, and the younger the diagnosis age was, the higher the lifelong medical expenses [33]. One two-center study on the treatment costs of Chinese Crohn's disease patients found that by 2011, the average hospitalization expenses of Crohn's disease patients had risen to CNY25504.21, an increase of 237% over 10 years ago [34]. The medical insurance policies of different provinces in China differ, and different reimbursement policies are formulated according to the severity of Crohn's disease, which also leads to different drug choices for patients.

Depression and anxiety are common in patients with IBD and are increasingly being recognized by gastroenterologists [35]. The psychological burden in IBD patients is threefold higher than that in the general population [36]. It is well documented that depression and anxiety may affect more than 25 to 30 percent of individuals with IBD [37, 38]. As expected, the results of the mixed methods in our study indicated that psychological burden is an unavoidable theme for patients with Crohn's disease. These psychological burdens come mainly from personal, family and social pressures. Some posts stated that the disease had caused many impacts on their families and made them vulnerable. These patients lived with low self-esteem, depression and anxiety. Patients with stoma mentioned suicide and death in some posts. A cohort study showed that intestinal surgery and stoma formation are positively associated with subsequent antidepressant medication use [39]. Some people could not support their parents and felt that they were a burden on their family, which caused them to bear a heavy mental burden. In addition, some patients had given up their original work, lifestyle and social contacts, and some had experienced great changes in their lives, such as breakups and divorce. IBD affects women differently than men. Truta’s review summarized the impact of IBD, Crohn's disease and ulcerative colitis on women's health, and found that women with Crohn's disease report worse psychological wellbeing less resilience than men but develop more escape and avoidance strategies to cope with the disease [40]. Our results also support the conclusion. We also found that most women with Crohn's disease were concerned about pregnancy. This is usually an important factor affecting marital happiness and family harmony, as traditional Chinese families need children to carry on the family lineage. IBD frequently affects women of childbearing age and may have implications for pregnancy [41]. Therefore, preconception counseling is pertinent to provide patient education, medication review for risk of teratogenicity and objective disease assessment.

Fortunately, we also found that peer support can play a role in encouragement. Psychological support is not incorporated into the routine care of persons with IBD. Some patients shared their successful treatment experiences, which relieved stress and gave confidence to other patients. Peer support provides a unique perspective of shared experience that can instill hope and assist coping efforts of patients and family [42]. A systematic review found that psychotherapeutic interventions can improve quality of life in patients with IBD and that early intervention after diagnosis leads to better coping strategies and quality of life throughout life [43]. Cumulatively, based on these results, we confirm that psychotherapy is necessary for IBD patients with mental stress.

Diet and nutrition are increasingly becoming matters of interest for Crohn's disease treatment, although they formerly played a marginal role [44]. Decreased dietary intake, nutrient malabsorption and weight loss are some of the nutritional challenges that Crohn's disease patients face [45]. Paradoxically, dietary intake may also trigger the symptoms of Crohn's disease patients [46]. Indeed, a Western-style diet rich in saturated fat and low in fiber has been implicated in the onset of the disease. This leads patients to seek dietary solutions for disease management [47]. However, current dietary recommendations are based largely on low-quality studies. At present, no clear indications of a specific diet are available. However, personalized nutrition is considered a potential way to treat patients with Crohn's disease [44]. One study explored the experience of dietary practices of Chinese patients with IBD and believed that health care professionals should encourage patients to report diet modification and be aware of both personal and environmental barriers to diet modification. [48]. Our study showed that patients with Crohn's disease are confused about their diet. Some posts shared menus and diet experiences with other patients. Vegetables, meat, fruits and beverages were mentioned repeatedly in posts. Malnutrition is detected in approximately 65–75% of patients with Crohn's disease [49]. Enteral nutrition (EN) and parenteral nutrition (PN) are recommended by the guidelines of the European Society of Clinical Nutrition and Metabolism (ESPEN) for malnourished patients [50]. Due to the high cost and side effects of PN, EN is often the first choice for Crohn's disease patients [51], and nasogastric feeding is the main EN method. One study explored the initial factors and experiences of nasogastric feeding by Crohn's disease patients from China, and the results suggested that many patients rejected nasogastric feeding due to fear, image and activity restrictions [52]. Nasogastric feeding is also an important term in our results. As mentioned above, the appearance problem caused by nasal feeding is one of the social pressures of Crohn's disease patients. Given women’s more fragile profile, they tend to be more affected by the effects of the disease than men, so it is necessary to carry out personalized nursing for female patients and improve their quality of life [40].

Weight is one of the nutritional concerns of Crohn's disease patients, who can simply judge their nutritional status by weight changes. However, 15 to 40% of patients with IBD are obese, which may lead to the development of IBD and make colorectal surgery technically challenging [53]. Recently, an integrative review suggested that physical activity can improve quality of life, mental health, sleep quality, fatigue and body weight [54]. In our study, exercise was one of the topics of concern for people with Crohn's disease. Many Crohn's disease patients do not know what and how much exercise will be beneficial. This suggests that the treatment of Crohn's disease requires the participation of nutritionists and exercise scientists to provide a more reasonable plan.

Our results reveal the poor quality of life of patients with Crohn's disease who suffer from intestinal symptoms, systemic symptoms, emotional function, etc. The Inflammatory Bowel Disease Questionnaire (IBDQ) is a valuable disease-specific quality of life questionnaire, that aids in identifying clinical disorientation in patients [55]. The IBDQ has been translated into many languages since its inception [56, 57], and has been used in many ways given its good reliability and validity. It has greatly contributed to evaluating the quality of life of patients and promoting the improvement of IBD diagnosis and treatment strategies. The mainland Chinese IBDQ has proven to be a valid, discriminative, and reliable instrument for assessing health-related quality of life in patients with ulcerative colitis and Crohn's disease in mainland China [57].

COVID-19 has caused a global health crisis, precisely in the country that is the cradle of the COVID-19 infection. In this study, four topics emerged on social media as the ones most discussed by Crohn's disease patients. In the face of this pandemic, patients with Crohn's disease are eager to receive advice on prevention and protection measures. Some researchers have recently provided patients with suggestions on IBD management [58], but at the beginning of the pandemic, there were no suggestion to provide. In addition, patients with Crohn's disease expressed concern about the shortage of medical resources. A study from the Netherlands showed that patients with IBD showed an overall low health-related quality of life during the COVID-19 pandemic, especially the older patients, women and patients who underwent surgical procedures [59]. Many hospitals temporarily closed the biological reagent injection room for the sake of epidemic safety, which led to many patients not being treated on time. Some radical and unprecedented health policies, such as shielding, disrupted patients’treatment and lives. Mass vaccination programs provide the best opportunity for controlling transmission and protecting populations [60], but this is a difficult decision for IBD patients as no confirmed data are presently available regarding COVID-19 vaccines in this population due to their exclusion from the conducted clinical trials [61]. The good news is that some recent studies have provided some clinical evidence [62,63,64]. Drug use after COVID-19 infection has also become a psychological burden for Crohn's disease patients. A clinical study of 1439 IBD patients from 47 countries showed that combination therapy (TNF antagonist and thiopurine) and thiopurine drugs may increase the risk of severe COVID-19. No significant differences were observed when comparing classes of biological agents [65], although post-acute COVID-19 is characterized by gut viral antigen persistence in IBD [66]. More clinical and basic studies are needed to confirm the problem of drug use after COVID-19 infection.


Social media is patient-centric and helps us better understand the experiences and perceptions of patients. Our study sheds light on the needs and difficulties of Chinese patients with Crohn's disease. In addition, this study can help medical staff predict the thoughts and concerns that Crohn's disease patients may have during the treatment process, facilitate doctor-patient communication, and assist in the formulation of medical policies.

Availability of data and materials

All the analysis data were accessed from the Crohn’s disease bar of Bait Tieba Online Website (


  1. Mak WY, et al. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol. 2020;35(3):380–9.

    Article  PubMed  Google Scholar 

  2. Ng SC, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.

    Article  PubMed  Google Scholar 

  3. Zheng JJ, et al. Prevalence and incidence rates of Crohn’s disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis. 2010;11(3):161–6.

    Article  PubMed  Google Scholar 

  4. Chi KR. Epidemiology: Rising in the East. Nature. 2016;540(7634):S100-s102.

    Article  CAS  PubMed  Google Scholar 

  5. Philippou A, et al. A Mixed-methods assessment of the impact of insurance issues on the emotional and physical health of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2022;28(12):1851–8.

    Article  PubMed  Google Scholar 

  6. Jordan C, et al. A qualitative study exploring the experience of people with IBD and elevated symptoms of anxiety and low mood and the type of psychological help they would like. Psychol Health. 2018;33(5):634–51.

    Article  PubMed  Google Scholar 

  7. Byron C, et al. Challenges of living with and managing inflammatory bowel disease: A meta-synthesis of patients’ experiences. J Clin Nurs. 2020;29(3–4):305–19.

    Article  PubMed  Google Scholar 

  8. Rouncefield-Swales A, et al. Sustaining, forming, and letting go of friendships for young people with inflammatory bowel disease (IBD): A qualitative interview-based study. Int J Chronic Dis. 2020;2020:7254972.

    PubMed  PubMed Central  Google Scholar 

  9. Jiang X, et al. Characteristics of online health care services from china’s largest online medical platform: cross-sectional survey study. J Med Internet Res. 2021;23(4):e25817.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gonzalez G, et al. Social media analytics of overactive bladder posts: what do patients know and want to know? Int Urogynecol J. 2021;32(10):2729–36.

    Article  PubMed  Google Scholar 

  11. O’Reilly M, et al. Is social media bad for mental health and wellbeing? Exploring the perspectives of adolescents. Clin Child Psychol Psychiatry. 2018;23(4):601–13.

    Article  PubMed  Google Scholar 

  12. Chan KL, Chen M. Effects of social media and mobile health apps on pregnancy care: meta-analysis. JMIR Mhealth Uhealth. 2019;7(1):e11836.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Li M, et al. Psychological impact of health risk communication and social media on college students during the covid-19 pandemic: cross-sectional study. J Med Internet Res. 2020;22(11):e20656.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Gao J, et al. Mental health problems and social media exposure during COVID-19 outbreak. PLoS ONE. 2020;15(4):e0231924.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Charmaz, K., The grounded theory method: An explication and interpretation. 1983.

  16. de la Espriella R, Gómez Restrepo C. Grounded theory. Rev Colomb Psiquiatr. 2020;49(2):127–33.

    Google Scholar 

  17. Turner C, Astin F. Grounded theory: what makes a grounded theory study? Eur J Cardiovasc Nurs. 2021;20(3):285–9.

    Article  PubMed  Google Scholar 

  18. Blei, D.M., A.Y. Ng, and M.I. Jordan, Latent dirichlet allocation. J. Mach. Learn. Res., 2003. 3(null): p. 993–1022.

  19. Xie T, Ping Q, Zhu L. Study on the topic mining and dynamic visualization in view of LDA model. Mod Appl Sci. 2018;13(1):204.

    Article  Google Scholar 

  20. Zhuang M, et al. Analysis of public opinion evolution of COVID-19 based on LDA-ARMA hybrid model. Complex Intell Systems. 2021;7(6):3165–78.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Zhang Y, Jin R, Zhou ZH. Understanding bag-of-words model: a statistical framework. Int J Mach Learn Cybern. 2010;1(1–4):43–52.

    Article  Google Scholar 

  22. Campbell IH, Rudan I. Helping global health topics go viral online. J Glob Health. 2020;8(1):010101.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Siegel CA. Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options. Gut. 2012;61(3):459–65.

    Article  PubMed  Google Scholar 

  24. Peng L, et al. Challenging the surge of IBD: the role of the china crohn’s and colitis foundation in the healthcare landscape of IBD. Inflamm Bowel Dis. 2022;28(Supplement_2):S9-15.

    Article  PubMed  Google Scholar 

  25. Wu Q, et al. Role of a multidisciplinary team (MDT) in the diagnosis, treatment, and outcomes of inflammatory bowel disease: a single Chinese center’s experience. Biosci Trends. 2021;15(3):171–9.

    Article  PubMed  Google Scholar 

  26. Cushing K, Higgins PDR. Management of crohn disease: a review. JAMA. 2021;325(1):69–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lichtenstein GR, et al. ACG clinical guideline: management of crohn’s disease in adults. Am J Gastroenterol. 2018;113(4):481–517.

    Article  PubMed  Google Scholar 

  28. Panaccione R, et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology. 2014;146(2):392-400.e3.

    Article  CAS  PubMed  Google Scholar 

  29. Colombel JF, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010;362(15):1383–95.

    Article  CAS  PubMed  Google Scholar 

  30. Cai Q, Wu L, Zhou Y. Experiences with traditional chinese medicine among patients with inflammatory bowel disease: a qualitative study. Gastroenterol Nurs. 2020;43(2):135–45.

    Article  PubMed  Google Scholar 

  31. Kou FS, et al. Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis: A multi-center, randomized, double-blind, controlled trial. Medicine (Baltimore). 2020;99(35):e21903.

    Article  CAS  PubMed  Google Scholar 

  32. Almario CV, et al. Optimizing selection of biologics in inflammatory bowel disease: development of an online patient decision aid using conjoint analysis. Am J Gastroenterol. 2018;113(1):58–71.

    Article  PubMed  Google Scholar 

  33. Lichtenstein GR, et al. Lifetime economic burden of Crohn’s disease and ulcerative colitis by age at diagnosis. Clin Gastroenterol Hepatol. 2020;18(4):889-897.e10.

    Article  PubMed  Google Scholar 

  34. Xu J, Tang M, Shen J. Trends and factors affecting hospitalization costs in patients with inflammatory bowel disease: a two-center study over the past decade. Gastroenterol Res Pract. 2013;2013:267630.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Cross, R.K. and L. Keefer, Chicken or Egg, Mental Health Disorders in Inflammatory Bowel Disease: Does It Matter? Gastroenterology, 2022.

  36. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009;15(7):1105–18.

    Article  PubMed  Google Scholar 

  37. Walker JR, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103(8):1989–97.

    Article  PubMed  Google Scholar 

  38. Guthrie E, et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease. Am J Gastroenterol. 2002;97(8):1994–9.

    Article  PubMed  Google Scholar 

  39. Blackwell J, et al. Stoma formation in Crohn’s disease and the likelihood of antidepressant use: a population-based cohort study. Clin Gastroenterol Hepatol. 2022;20(4):e703–10.

    Article  CAS  PubMed  Google Scholar 

  40. Truta B. The impact of inflammatory bowel disease on women’s lives. Curr Opin Gastroenterol. 2021;37(4):306–12.

    Article  PubMed  Google Scholar 

  41. Laube R, Paramsothy S, Leong RW. Review of pregnancy in Crohn’s disease and ulcerative colitis. Therap Adv Gastroenterol. 2021;14:17562848211016242.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Badger K, Acton A, Peterson P. Aftercare, survivorship, and peer support. Clin Plast Surg. 2017;44(4):885–91.

    Article  PubMed  Google Scholar 

  43. Paulides E, et al. the effect of psychotherapy on quality of life in IBD patients: a systematic review. Inflamm Bowel Dis. 2021;27(5):711–24.

    Article  PubMed  Google Scholar 

  44. Caio G, et al. Nutritional Treatment in Crohn's Disease. Nutrients. 2021;13(5):1628.

  45. Vidarsdottir JB, et al. A cross-sectional study on nutrient intake and -status in inflammatory bowel disease patients. Nutr J. 2016;15(1):61.

    Article  PubMed  PubMed Central  Google Scholar 

  46. MacDermott RP. Treatment of irritable bowel syndrome in outpatients with inflammatory bowel disease using a food and beverage intolerance, food and beverage avoidance diet. Inflamm Bowel Dis. 2007;13(1):91–6.

    Article  PubMed  Google Scholar 

  47. Yelencich E, et al. Avoidant restrictive food intake disorder prevalent among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2022;20(6):1282-1289.e1.

    Article  CAS  PubMed  Google Scholar 

  48. Zhou Y, Ma X, Chen Y. Dietary practices of Chinese patients with inflammatory bowel disease: a naturalistic inquiry. Gastroenterol Nurs. 2014;37(1):60–9.

    Article  CAS  PubMed  Google Scholar 

  49. Scaldaferri F, et al. Nutrition and IBD: malnutrition and/or sarcopenia? A Practical Guide Gastroenterol Res Pract. 2017;2017:8646495.

    CAS  PubMed  Google Scholar 

  50. Bischoff SC, et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Nutr Hosp. 2022;39(3):678–703.

    PubMed  Google Scholar 

  51. Weimann A, et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. 2017;36(3):623–50.

    Article  PubMed  Google Scholar 

  52. Cai Q, Li F, Zhou Y. Experiences of Chinese patients with Crohn’s disease in the self-administration of nasogastric feeding: A descriptive qualitative study. PLoS ONE. 2018;13(7):e0201421.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Singh S, et al. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14(2):110–21.

    Article  CAS  PubMed  Google Scholar 

  54. Davis SP, et al. An integrative review of physical activity in adults with inflammatory bowel disease. Intest Res. 2022;20(1):43–52.

    Article  PubMed  Google Scholar 

  55. Guyatt G, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96(3):804–10.

    Article  CAS  PubMed  Google Scholar 

  56. Russel MG, et al. Validation of the dutch translation of the inflammatory bowel disease questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion. 1997;58(3):282–8.

    Article  CAS  PubMed  Google Scholar 

  57. Ren WH, et al. Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 2007;13(7):903–10.

    Article  CAS  PubMed  Google Scholar 

  58. Magro F, et al. Inflammatory bowel disease management during the covid-19 outbreak: The ten do’s and don’ts from the ECCO-COVID Taskforce. J Crohns Colitis. 2020;14(14 Suppl 3):S798-s806.

    Article  CAS  PubMed  Google Scholar 

  59. de Bock E, et al. Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands. BMJ Open Gastroenterol. 2021;8(1):e000670.

    Article  PubMed  Google Scholar 

  60. Alexander JL, et al. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British society of gastroenterology inflammatory bowel disease section and IBD clinical research group position statement. Lancet Gastroenterol Hepatol. 2021;6(3):218–24.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Negahdaripour M, et al. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol. 2021;99:108021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Lev-Tzion R, et al. COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation. Clin Gastroenterol Hepatol. 2022;20(6):e1263–82.

    Article  CAS  PubMed  Google Scholar 

  63. Alexander JL, et al. COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study. Lancet Gastroenterol Hepatol. 2022;7(11):1005–15.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Kubas A, Malecka-Wojciesko E. COVID-19 vaccination in Inflammatory Bowel Disease (IBD). J Clin Med. 2022;11(9):2676.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Ungaro RC, et al. Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 2021;70(4):725–32.

    Article  CAS  PubMed  Google Scholar 

  66. Zollner A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(2):495-506.e8.

    Article  CAS  PubMed  Google Scholar 

Download references


The authors of this study express their heartfelt thanks to the data provided by Baidu Tieba.


This publication was funded by National Science Foundation of China (Grant no. 81970470), the Zhejiang Provincial Nature Foundation of China (Grant no. LQ21H030001) and the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (Grant no.2021KY828).

Author information

Authors and Affiliations



Shaopeng Sun, Yunhong Hu and Heng Li wrote the main manuscript text; Jiajia Chen and Yijie Lou analyzed the data; Chunyan Weng and Lixia Chen prepared the figures; Bin Lv designed this study and revised the article. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Bin Lv.

Ethics declarations

Ethics approval and consent to participate

Not Applicable.

Consent for publication

Not Applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, S., Hu, Y., Li, H. et al. Patients’ perspectives on, experience with and concerns about crohn's disease: insights from Chinese social media. BMC Gastroenterol 23, 105 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: